Posted by Editorial Team on Dec 2nd, 2024
AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) was the target of a significant growth in short interest in November. As of November 15th, there was short interest totalling 6,710,000 shares, a growth of 8.6% from the October...
More of this article »